Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v4-FR
Language French French
Date Updated 2021-01-13 2020-12-03
Drug Identification Number 02020017 02020017
Brand name LIVOSTIN SUS NAS 0.5MG/ML LIVOSTIN SUS NAS 0.5MG/ML
Common or Proper name LIVOSTIN LIVOSTIN
Company Name JANSSEN INC JANSSEN INC
Ingredients LEVOCABASTINE LEVOCABASTINE
Strength(s) 0.05MG 0.05MG
Dosage form(s) SUSPENSION SPRAY SUSPENSION SPRAY
Route of administration NASAL NASAL NASAL NASAL
Packaging size 1x1 1x1
ATC code R01AC R01AC
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-01-01 2021-01-01
Actual discontinuation date 2021-01-12
Remaining supply date 2020-12-24 2020-12-24
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments